Electrical Vestibular Stimulation for Dizziness
(VST Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research on a similar treatment, electrotactile vestibular substitution system (EVSS), showed that patients with vestibular loss experienced improved balance and reduced dizziness after using the system. Additionally, studies on electric stimulation in animals indicated faster recovery from balance issues, suggesting potential benefits for dizziness treatment.
12345Studies show that electrical vestibular stimulation (EVS) is generally safe for humans, with no reported side effects in a study involving stroke patients and a focus on long-term usage safety in another study.
678910Electrical Vestibular Stimulation (EVS) is unique because it uses electrical currents to directly stimulate the vestibular system, which is responsible for balance and spatial orientation. Unlike traditional treatments like medication or surgery, EVS aims to artificially restore vestibular function and has shown promise in improving balance and reducing dizziness by enhancing vestibular compensation.
211121314Eligibility Criteria
This trial is for healthy individuals who experience dizziness and are interested in testing a non-invasive treatment to improve balance and gait. Specific eligibility criteria details were not provided, so general health status may be considered.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 18 sessions of electrical vestibular stimulation (EVS) over a 5-6 week period to improve balance and gait performance.
Follow-up
Participants are monitored for persistence of performance improvements with follow-up sessions at 3 weeks, 6 weeks, 3 months, and 6 months post-treatment.